PYXS is trading at 5.3% up now at $3.00 as the stock stabilizes after a sharp drop tied to its $114 million private placement priced below market. Investors appear to be digesting the expected dilution and refocusing on the company’s cash runway and oncology pipeline, with today’s move also broadly aligned with strength in major U.S. indices.